TBS-2025

N/A

Report date: 2025/12/05 11:43:42

Base Information

Drug NameTBS-2025
Drug Alias NameTBS-2025
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-V-domain Ig suppressor of T-cell activation
TargetsV-domain Ig suppressor of T-cell activation
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKintara Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKintara Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A